Health Care; Pharmaceutical; Diagnostic; Biotech; Consumer Products; Medical Device; Manufacturing; Chemical; Service; Technology
Abbott; Abbott Laboratories; Actelion; Alcon; Allergan; Almirall; Altus Biologics; Amgen; Amylin; ARIAD; Astellas; AstraZeneca; Auxilium; Bausch & Lomb; Baxter International; Bayer; Bayer Healthcare; Biogen Idec; Boehringer Ingelheim; Bristol-Myers Squibb; Daiichi Pharmaceutical Co.; Dr Reddy's Laboratories; Eli Lilly; EMD Serono; Genentech; Genitope Corporation; Genzyme; GlaxoSmithKline; Human Genome Sciences; Inc.; Inspire Pharmaceuticals; Integrated Communications Corp.; Janssen Cilag Pharmaceutical; Johnson & Johnson; Lilly; Ltd.; Lundbeck; Merck; NeoVista; Nobel Biocare; Novartis; Noven Therapeuticals; Novo Nordisk; Onyx Pharmaceuticals; Ortho Biotech; Pfizer; ProStrakan; Regeneron; Roche; Sanofi-aventis; Shire; Smith & Nephew; Solvay Pharmaceuticals; Spectrum Pharmaceutical; Stiefel; Takeda Pharmaceuticals; Theravance; UCB Pharma; Victory; Xanodyne Pharmaceuticals
Who Can Benefit From These Services?
These services are specifically designed to provide comprehensive coverage on effective strategies and tactics in new product planning. Pharmaceutical executives can use this benchmarking research to learn best practices in New Product Planning management and discover how they can maximize launch activities in competitive markets.